BioSpace News Archive

Sept. 21, 2022 20:05 UTC Agilent Technologies Inc. announced a quarterly dividend of 21 cents per share of common stock will be paid on October 26, 2022, to all shareholders of record as of the close of business on October 4, 2022.

Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today that the European Medicines Agency (EMA) Pediatric Committee (PDCO) has adopted a positive opinion on the Pediatric Investigation Plan (PIP) for beremagene geperpavec (B-VEC) for the treatment of dystrophic epidermolysis bullosa.

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today named Rutul R. Shah as the Company’s Chief Operating Officer (COO), effective October 1, 2022.

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of neurological disorders, today announced the presentation of a clinical case study from the initial dose cohort of the Phase 1/2 first-in-human epilepsy clinical trial of its lead program, NRTX-1001.

Aidoc, the leading provider of healthcare AI solutions, announced that it is now live in the Epic App Orchard, enabling efficient integration with Epic’s Electronic Health Records platform.

3Shape introduced TRIOS 5 Wireless, a completely new, state-of-the-art intraoral scanner designed to make it easier than ever for dentists to go digital with their dentistry.

Dr. Amir Bajoghli and medical assistants Gabriela Hernandez and Helen Kemprecos of Skin and Laser Dermatology Center, along with their co-authors, recently published a rare case of lyme disease in the dermatological journal, Cutis.